1. Home
  2. 2018 Newly Designed E

2018 Newly Designed E

2019-11-10Purpose Bosutinib is a potent dual SRCABL kinase inhibitor approved for adults with Philadelphia chromosomepositive chronic myeloid leukemia CML resistant and or intolerant to prior therapy.

Get Price